Top Stories

Riding the momentum of the application infrastructure and middleware market, Cleo grows 20% annually or more, according to a source.

Datavant's tokenization technology is poised to dramatically transform the growth trajectory of Ciox, which has already built an expansive network for the exchange of clinical data.

The healthcare technology company is an example of Temasek’s quiet but quick penetration in the North American buyout market, which has grown from 0 percent to 17 percent of its net portfolio value as of March 2020.

Advised by Berkery Noyes, the company has reached out to a number of PE firms in the past two months.

Betting on the importance of healthcare’s infrastructure, three prominent PE firms back a secretive family-run company that has quietly proven a growth-machine in healthcare products distribution.

The company, majority owned by Prospect Hill, will accelerate growth by tapping into Blackstone’s in-house data science team and warehousing capabilities.

The firms hired Morgan Stanley to advise on the cybersecurity company's sale process, which is expected to launch later in June, the people said.

The clinical site organization's concentrated model offering centralized capabilities is considered compelling to pharma companies and CROs looking to depend on fewer outsourced providers.

Exiting investor Dubin Clark makes more than 5x its money on the home services company, with more M&A on the horizon under its new backer.